FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

21275011000001107: Jakavi 5mg tablets (Novartis Pharmaceuticals UK Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 17-Oct 2012. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
70967901000001112 Jakavi 5mg tablets (Novartis Pharmaceuticals UK Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
70968001000001114 Jakavi 5mg tablets (Novartis Pharmaceuticals UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Jakavi 5mg tablets (Novartis Pharmaceuticals UK Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Jakavi 5mg tablets (Novartis Pharmaceuticals UK Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Jakavi 5mg tablets (Novartis Pharmaceuticals UK Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Jakavi 5mg tablets (Novartis Pharmaceuticals UK Ltd) Is a Ruxolitinib 5mg tablets true Inferred relationship Existential restriction modifier
Jakavi 5mg tablets (Novartis Pharmaceuticals UK Ltd) Is a Ruxolitinib 5mg tablets false Inferred relationship Existential restriction modifier
Jakavi 5mg tablets (Novartis Pharmaceuticals UK Ltd) Is a Ruxolitinib 5mg tablets false Inferred relationship Existential restriction modifier
Jakavi 5mg tablets (Novartis Pharmaceuticals UK Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Jakavi 5mg tablets (Novartis Pharmaceuticals UK Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Jakavi 5mg tablets (Novartis Pharmaceuticals UK Ltd) Has specific active ingredient Ruxolitinib phosphate false Inferred relationship Existential restriction modifier
Jakavi 5mg tablets (Novartis Pharmaceuticals UK Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Jakavi 5mg tablets (Novartis Pharmaceuticals UK Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Ruxolitinib false Inferred relationship Existential restriction modifier
Jakavi 5mg tablets (Novartis Pharmaceuticals UK Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Jakavi 5mg tablets (Novartis Pharmaceuticals UK Ltd) Is a Jakavi true Inferred relationship Existential restriction modifier
Jakavi 5mg tablets (Novartis Pharmaceuticals UK Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Jakavi 5mg tablets (Novartis Pharmaceuticals UK Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Ruxolitinib true Inferred relationship Existential restriction modifier
Jakavi 5mg tablets (Novartis Pharmaceuticals UK Ltd) Has active ingredient Ruxolitinib false Inferred relationship Existential restriction modifier
Jakavi 5mg tablets (Novartis Pharmaceuticals UK Ltd) Is a Product containing precisely ruxolitinib 5 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Jakavi 5mg tablets (Novartis Pharmaceuticals UK Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Jakavi 5mg tablets (Novartis Pharmaceuticals UK Ltd) Has basis of strength substance Ruxolitinib true Inferred relationship Existential restriction modifier
Jakavi 5mg tablets (Novartis Pharmaceuticals UK Ltd) Has specific active ingredient Ruxolitinib phosphate true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Jakavi 5mg tablets (Novartis Pharmaceuticals UK Ltd) 60 tablet Has AMP True Jakavi 5mg tablets (Novartis Pharmaceuticals UK Ltd) Inferred relationship Existential restriction modifier
Jakavi 5mg tablets (Novartis Pharmaceuticals UK Ltd) 56 tablet 4 x 14 tablets Has AMP True Jakavi 5mg tablets (Novartis Pharmaceuticals UK Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start